Premier Alternatives

HighLife

Paris, France · Founded 2010 · Privately Held (backing)

Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. HighLife is based in Paris, France and was founded in 2010. It was valued at $534 million at its later-stage round in Sep 2026, the last priced event on record. It has raised $71 million across 1 recorded round; the latest was a $90 million later-stage round in Sep 2026.

PMV mark · valuation
$534.1M
Oct 2026
Priced at
its later-stage round
Sep 2026
Total raised
$71.0M
Last round
Later Stage VC
Sep 2026

HighLife key facts

as of Oct 2026
  • Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation.
  • HighLife is valued at approximately $534.1M as of Oct 2026, set at its later-stage round, Sep 2026; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $71.0M across 1 recorded rounds; the latest was Later Stage VC ($90.0M) in Sep 2026.
  • Notable investors include Supernova Invest, Sofinnova Partners, BNP Paribas Développement, European Investment Bank, Andera Partners — 14 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
MEDIUM confidence
$534.1M

Valued at $534.1M at its later-stage round, Sep 2026. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of HighLife with a free account
  • ·The post-money valuation on its round
  • ·The complete investor list: 14 names
  • ·Watch HighLife: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

HighLife funding rounds

1 rounds
Sep 2026Later Stage VC$90.0M▮
Full funding history →

HighLife valuation

HighLife was valued at $534 million at its later-stage round in Sep 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

Recent activity

In the last 90 days, HighLife's record added 1 funding round.

How much has HighLife raised?

HighLife has raised $71 million across 1 recorded round since 2026. The largest was a $90 million later-stage round in Sep 2026. 1 of the rounds disclosed a post-money valuation.

HighLife investors

14 investors are on record for HighLife, including Supernova Invest, Sofinnova Partners, BNP Paribas Développement and European Investment Bank. By type, the record holds 3 venture capital firms and 3 private equity firms. 1 of them led a round. The later-stage round in Sep 2026 drew 13 investors.

About HighLife

Developer of a novel transcatheter replacement system designed to help in the treatment of mitral regurgitation. The company's system targets optimal treatment outcomes as it can be delivered through a transseptal passage via the femoral vein in a reversible manner and self-locates inside the native annulus, enabling physicians to reduce trauma to the patients while carrying out severe heart surgery procedures.

Sector
Healthcare
HQ
Paris, France
Founded
2010
Employees
70
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.